Partial STX11 deficiency due to a hypomorphic variant—self-limiting inflammatory disease preceding HLH onset
Recently developed in vitro technology was used to define the function of a previously uncharacterized STX11 mutation L135P present in a patient with atypical FHL. The results confirmed the FHL diagnosis and enabled clinicians to proceed with assurance to hematopoietic stem cell transplantation.
Authors
- Ilia Voskoboinik (ORCID: https://orcid.org/0000-0002-6410-009X)
- A Kaur (ORCID: https://orcid.org/0000-0002-9862-1870)
- Aaqib Zaffar Banday (ORCID: https://orcid.org/0000-0001-5486-4267)
- Tahereh Noori (ORCID: https://orcid.org/0000-0002-8746-5841)
- Altaf Hussain Kambay
Institutions
- Government Medical College (IN)
- Peter MacCallum Cancer Centre (AU)
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Journal of Human Immunity
- Published
- 2025-10-07
- DOI
- https://doi.org/10.70962/jhi.20250100
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peter MacCallum Cancer Centre
- Medical Research Council
- National Health and Medical Research Council